All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
MRNA real return snapshot: after CPI-U inflation, MRNA returned +65.49% over the past year and +58.45% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +95.26% in real purchasing-power return, or +9.40%/yr, and is currently −91.87% below its real total-return high on Aug. 9, 2021.
| Fri 2018-12-07? to Wed 2026-05-20 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+58.45%
2026-05-20 |
+65.49%
2026-05-20 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Wed 2026-05-20 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+95.26%
+9.40%/yr |
+0.45%/yr
(R2=0.000) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Wed 2026-05-20 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$19,525.61
2026-05-20 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2026 (YTD) | +58.45% |
| 2025 | −30.92% |
| 2024 | −59.36% |
| 2023 | −46.43% |
| 2022 | −33.57% |
| 2021 | +127.13% |
| 2020 | +426.92% |
| 2019 | +25.23% |
| 2018 | −17.70% |
| Fri 2018-12-07? to Wed 2026-05-20 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × |
−91.87%
from 2021-08-09 peak |
−96.11%
2025-11-20 from 2021-08-09 peak |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Period ending Wed 2026-05-20 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| MRNA × | +65.49% |
−67.90% −43.37%/yr |
−65.29% −29.70%/yr |
−76.68% −25.26%/yr |
— | |
| Moderna Inc NASDAQ Common Stock | ||||||